Author

M. Trivedi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Evolutionary Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

, I. Makhoul· 1 shared A. Bardia· 1 shared A. Bhattacharya· 1 shared A. Bild· 1 shared A. L. Cohen· 1 shared A. Mackey· 1 shared A. O'Dea· 1 shared C. Arze· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

, I. Makhoul

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Historical demography and species distribution models shed light on past speciation in primates of northeast India

M. Trivedi, K. D. Arekar, G. Umapathy

This study uses historical demography and species distribution models to analyze the evolutionary dynamics of primate species in northeast India.

bioRxiv · Feb 25, 2023Evolutionary Biology

Human anelloviruses produced by recombinant expression of synthetic genomes.

D. M. Nawandar, M. Trivedi, G. Bounoutas, K. Lebo, C. Prince, C. Scano, N. Agarwal, E. Ozturk, J. Yu, C. Arze, A. Bhattacharya, D. Verma, P. Thakker, J. Cabral, S.-H. Liu, , S. Delagrave

This paper demonstrates the production of human anelloviruses in vitro using synthetic genomes in MOLT-4 cells, showing infectivity in mice and enabling further virology studies.

bioRxiv · Apr 28, 2022 · PreprintMicrobiology

Convergent evolution of resistance pathways during early stage breast cancer treatment with combination cell cycle (CDK) and endocrine inhibitors

J. I. Griffiths, J. Chen, P. A. Cosgrove, A. O'Dea, P. Sharma, C. Ma, M. Trivedi, K. Kalinsky, K. B. Wisinski, R. O'Regan, , I. Makhoul, L. M. Spring, A. Bardia, F. R. Adler, A. L. Cohen, , A. Bild

This study examines how breast cancer tumors evolve during early stage treatment with combination CDK and endocrine inhibitors, finding convergent resistance pathways and increased subclonal diversity with combination therapy.

bioRxiv · Jan 19, 2021 · PreprintCancer Biology